 SAN DIEGO, April 12, 2021 GLOBE NEWSWIRE -- Maravai LifeSciences Holdings, Inc. Maravai NASDAQ: MRVI, a global provider of life science reagents and services to researchers and biotech innovators, today announced the closing of a public offering of 20,700,000 shares of Maravais Class A common stock by certain selling stockholders that was previously announced, including the full exercise of the underwriters option to purchase up to 2,700,000 additional shares of Class A common stock, at a price of 31.25 per share. 